Levêque D - Search Results

1

Assessment of high-priced systemic antifungal prescriptions.

Poulat C, Nivoix Y, Launoy A, Lutun P, Bachellier P, Rohr S, Woehl ML, Levêque D, Bru V, Herbrecht R, Gourieux B. Poulat C, et al. Among authors: leveque d. Med Mal Infect. 2017 Oct;47(6):382-388. doi: 10.1016/j.medmal.2017.03.004. Epub 2017 Apr 13. Med Mal Infect. 2017. PMID: 28412043

2

Combination of caspofungin and an azole or an amphotericin B formulation in invasive fungal infections.

Nivoix Y, Zamfir A, Lutun P, Kara F, Remy V, Lioure B, Rigolot JC, Entz-Werlé N, Letscher-Bru V, Waller J, Levêque D, Koffel JC, Beretz L, Herbrecht R. Nivoix Y, et al. Among authors: leveque d. J Infect. 2006 Jan;52(1):67-74. doi: 10.1016/j.jinf.2005.01.006. J Infect. 2006. PMID: 16368463

3

Clinical pharmacokinetics of voriconazole.

Levêque D, Nivoix Y, Jehl F, Herbrecht R. Levêque D, et al. Int J Antimicrob Agents. 2006 Apr;27(4):274-84. doi: 10.1016/j.ijantimicag.2006.01.003. Epub 2006 Mar 24. Int J Antimicrob Agents. 2006. PMID: 16563707 Review.

4

The enzymatic basis of drug-drug interactions with systemic triazole antifungals.

Nivoix Y, Levêque D, Herbrecht R, Koffel JC, Beretz L, Ubeaud-Sequier G. Nivoix Y, et al. Among authors: leveque d. Clin Pharmacokinet. 2008;47(12):779-92. doi: 10.2165/0003088-200847120-00003. Clin Pharmacokinet. 2008. PMID: 19026034 Review.

5

Drug-drug interactions of triazole antifungal agents in multimorbid patients and implications for patient care.

Nivoix Y, Ubeaud-Sequier G, Engel P, Levêque D, Herbrecht R. Nivoix Y, et al. Among authors: leveque d. Curr Drug Metab. 2009 May;10(4):395-409. doi: 10.2174/138920009788499012. Curr Drug Metab. 2009. PMID: 19519346 Review.

6

[Mechanisms of pharmacokinetic drug-drug interactions].

Levêque D, Lemachatti J, Nivoix Y, Coliat P, Santucci R, Ubeaud-Séquier G, Beretz L, Vinzio S. Levêque D, et al. Rev Med Interne. 2010 Feb;31(2):170-9. doi: 10.1016/j.revmed.2009.07.009. Epub 2009 Sep 8. Rev Med Interne. 2010. PMID: 19740579 Review. French.

7

Paralytic ileus possibly associated with interaction between ritonavir/lopinavir and vincristine.

Levêque D, Santucci R, Pavillet J, Herbrecht R, Bergerat JP. Levêque D, et al. Pharm World Sci. 2009 Dec;31(6):619-21. doi: 10.1007/s11096-009-9323-y. Epub 2009 Sep 10. Pharm World Sci. 2009. PMID: 19757141

8

Severe intoxication with methotrexate possibly associated with concomitant use of proton pump inhibitors.

Santucci R, Levêque D, Kemmel V, Lutz P, Gérout AC, N'guyen A, Lescoute A, Schneider F, Bergerat JP, Herbrecht R. Santucci R, et al. Among authors: leveque d. Anticancer Res. 2010 Mar;30(3):963-5. Anticancer Res. 2010. PMID: 20393020

9

Delayed elimination of methotrexate associated with co-administration of proton pump inhibitors.

Santucci R, Levêque D, Lescoute A, Kemmel V, Herbrecht R. Santucci R, et al. Among authors: leveque d. Anticancer Res. 2010 Sep;30(9):3807-10. Anticancer Res. 2010. PMID: 20944174

10

[Potential clinical impact of therapeutic education in patients treated with anticancer drugs].

Santucci R, Aatmani AE, Lescoute A, Levêque D, Serra S, Bergerat JP, Beretz L, Herbrecht R. Santucci R, et al. Among authors: leveque d. Bull Cancer. 2011 Feb;98(2):176-81. doi: 10.1684/bdc.2011.1308. Bull Cancer. 2011. PMID: 21382797 French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

100 results

Search Page

Filters